Pub. Date : 2012
PMID : 22863914
6 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Tamibarotene (Am80), a synthetic retinoid approved in Japan for treatment of acute promyelocytic leukemia (APL), is a retinoic acid receptor (RAR) agonist with high specificity for RARalpha and RARbeta over RARgamma. | tamibarotene | retinoic acid receptor, alpha | Rattus norvegicus |
| 2 | Tamibarotene (Am80), a synthetic retinoid approved in Japan for treatment of acute promyelocytic leukemia (APL), is a retinoic acid receptor (RAR) agonist with high specificity for RARalpha and RARbeta over RARgamma. | tamibarotene | retinoic acid receptor, alpha | Rattus norvegicus |
| 3 | Tamibarotene (Am80), a synthetic retinoid approved in Japan for treatment of acute promyelocytic leukemia (APL), is a retinoic acid receptor (RAR) agonist with high specificity for RARalpha and RARbeta over RARgamma. | tamibarotene | retinoic acid receptor, alpha | Rattus norvegicus |
| 4 | Tamibarotene (Am80), a synthetic retinoid approved in Japan for treatment of acute promyelocytic leukemia (APL), is a retinoic acid receptor (RAR) agonist with high specificity for RARalpha and RARbeta over RARgamma. | tamibarotene | retinoic acid receptor, alpha | Rattus norvegicus |
| 5 | Tamibarotene (Am80), a synthetic retinoid approved in Japan for treatment of acute promyelocytic leukemia (APL), is a retinoic acid receptor (RAR) agonist with high specificity for RARalpha and RARbeta over RARgamma. | tamibarotene | retinoic acid receptor, alpha | Rattus norvegicus |
| 6 | Tamibarotene (Am80), a synthetic retinoid approved in Japan for treatment of acute promyelocytic leukemia (APL), is a retinoic acid receptor (RAR) agonist with high specificity for RARalpha and RARbeta over RARgamma. | tamibarotene | retinoic acid receptor, alpha | Rattus norvegicus |